At a glance
ClinicalIndex Comparison RecordN/ACompleted· 67 enrolled
Drug / intervention
nicotine replacement therapy +4 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
International Study of the Acceptability of Less Harmful Alternatives to Cigarettes (ISALHAC) - A Pilot Study
In Brief
A clinical study evaluating telephone-based intervention, nicotine replacement therapy, and 3 other interventions for Bladder Cancer and 10 related conditions. Completed, enrolled 67 participants across 1 site.
Detailed Summary
RATIONALE: A study that evaluates participants' beliefs about smokeless tobacco products and nicotine replacement therapy may be useful in helping smokers stop smoking. PURPOSE: This clinical trial is studying the acceptability of less harmful alternatives to cigarettes.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBladder Cancer, Cervical Cancer, Esophageal Cancer, Gastric Cancer, Head and Neck Cancer, Kidney Cancer, Leukemia, Liver Cancer, Lung Cancer, Pancreatic Cancer, Tobacco Use Disorder
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJun 2009
Primary CompletionAug 2009
First PostedAug 2009
Study CompletionNov 2011
TodayJul 2026
First PostedAug 12, 2009
Enrollment StartJun 1, 2009
Primary CompletionAug 1, 2009
Study CompletionNov 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 16.9 years ago
Interventions
telephone-based interventionbehavioral
10-15 minute web-based survey on a computer
nicotine replacement therapydrug
One week supply
informational interventionother
internet-based interventionother
questionnaire administrationother
Given out week 2, 3 and 4.